John J. Won

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan, Amy Sims, Sarah R. Leist et al. · Nature Communications · 2020 · 1.8K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

Ariane J. Brown, John J. Won, Rachel L. Graham et al. · Antiviral Research · 2019 · 531 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14

Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice

Alexandra Schäfer, David R. Martinez, John J. Won et al. · Science Translational Medicine · 2022 · 83 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice

Alexandra Schäfer, David R. Martinez, John J. Won et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 24 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Host genetic variation guides hepacivirus clearance, chronicity, and liver fibrosis in mice

Ariane J. Brown, John J. Won, Raphael Wolfisberg et al. · Hepatology · 2023 · 17 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17